Effects of dose modifications on the safety and efficacy of dacomitinib for EGFR mutation-positive non-small-cell lung cancer.
Saved in:
| Title: | Effects of dose modifications on the safety and efficacy of dacomitinib for EGFR mutation-positive non-small-cell lung cancer. |
|---|---|
| Authors: | Corral J; Clínica Universidad de Navarra, Madrid, 28027, Spain., Mok TS; State Key Laboratory of South China, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, PR China., Nakagawa K; Kindai University Hospital, Osaka, 589-8511, Japan., Rosell R; Catalan Institute of Oncology, Barcelona, Spain., Lee KH; Chungbuk National University Hospital, Cheongju, Korea., Migliorino MR; Pulmonary Oncology Unit, San Camillo-Forlanini Hospital, Rome, 00152, Italy., Pluzanski A; The Maria Sklodowska-Curie Memorial Cancer Centre & Institute of Oncology, Warsaw, 02-781, Poland., Linke R; SFJ Pharmaceuticals®, Pleasanton, CA 94588, USA., Devgan G; Pfizer Oncology, New York, NY 10017, USA., Tan W; Pfizer Clinical Pharmacology, San Diego, CA 92121, USA., Quinn S; Pfizer Oncology, Cambridge, MA 02139, USA., Wang T; Pfizer Oncology, Groton, CT 06340, USA., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, PR China. |
| Source: | Future oncology (London, England) [Future Oncol] 2019 Aug; Vol. 15 (24), pp. 2795-2805. Date of Electronic Publication: 2019 Jul 17. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
